InvestorsHub Logo
Followers 33
Posts 2049
Boards Moderated 0
Alias Born 11/06/2011

Re: attilathehunt post# 31055

Sunday, 03/21/2021 6:31:09 PM

Sunday, March 21, 2021 6:31:09 PM

Post# of 34623
There is no way this is approved in 90 days. That is not how any of this works. They need to run the trial, submit the BLA, and wait for FDA review. The FDA isn't just going to approve a therapy that literally just started a PII trial. This is one of the craziest things I have heard said on this board.

If you are referring to the lymphoma data published in the Journal of Clinical Oncology that was not new data. It is the PI data that they have already presented. It was not an abstract submitted anywhere. You are saying abstract because the link the was posted to this board was an abstract of the journal. No the whole journal article.


No explanation on reason for build out of Manu facility



You clearly have not been paying enough attention as the company 100% provided an explanation on the facility. They are running a pivotal PII trial that they will be looking to gain approval from without the need for a PIII. In a pivotal PII the FDA requires that a majority of the product used in the trial is manufactured in the same facility that will produce the end product once approved. This is the main reason they decided to build out a facility.

An unneeded secondary (at a price that was manufactured to be low)...Yes, manufactured to stay low so they could proceed with secondary for the benefit of insiders.


They were set to run out of cash in Q1 of next year, They 100% needed cash before the end of the year. You say manufactured to be low but that just shows your lack of understanding how these things work. They were not negotiating the terms of that offering from a position of strength. Also, of Peter, Juan Vera, and John Wilson are the only insiders who purchased shares in the offering. They had to give a dollar commitment before it was priced so while they new it was going to be lower than current market pricing they did not know where it would end up prior to placing their commitments. You do realize most of that offering went to other entities right?

With accelerated approval in 2021, there was NO NEED for the secondary.



They aren't getting approval in 2021 so, yes, they needed funds per my statements above.

Where the hell did you come up with any of this?

Friends don't let friends place market orders

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MRKR News